Health Care & Life Sciences » Pharmaceuticals | China Medical System Holdings Ltd.

China Medical System Holdings Ltd. | Balance Sheet

Fiscal year is January-December. All values HKD Millions.
2013
2014
2015
2016
2017
2018
Cash & Short Term Investments
1,190
566
607
538
1,027
929
Total Accounts Receivable
686
950
1,370
2,742
1,842
2,080
Inventories
212
281
488
608
553
496
Other Current Assets
407
135
59
74
131
81
Total Current Assets
2,497
1,932
2,524
3,962
3,553
3,586
Net Property, Plant & Equipment
402
317
541
404
575
545
Total Investments and Advances
165
1,636
1,578
1,521
2,938
3,154
Long-Term Note Receivable
-
14
13
12
-
-
Intangible Assets
1,712
2,032
2,877
4,764
4,928
4,491
Other Assets
76
177
73
228
157
181
Total Assets
4,877
6,131
7,636
10,924
12,183
11,981
ST Debt & Current Portion LT Debt
407
612
570
3,022
78
Accounts Payable
86
99
114
154
156
Income Tax Payable
50
82
83
152
93
Other Current Liabilities
208
192
311
461
463
Total Current Liabilities
751
986
1,078
3,789
790
Long-Term Debt
28
56
40
25
2,449
Deferred Taxes
12
77
100
84
93
Other Liabilities
-
-
-
-
21
Total Liabilities
815
1,143
1,247
3,931
3,386
Common Equity (Total)
4,045
4,988
6,321
6,927
8,733
Total Shareholders' Equity
4,045
4,988
6,321
6,927
8,733
Total Equity
4,062
4,988
6,388
6,993
8,797
Liabilities & Shareholders' Equity
4,877
6,131
7,636
10,924
12,183
Accumulated Minority Interest
17
-
67
65
64

About China Medical System Holdings

View Profile
Address
6/F-8/F, Block B
Shenzhen Guangdong 518052
China
Employees -
Website http://www.cms.net.cn
Updated 07/08/2019
China Medical System Holdings Ltd. engages in the provision of pharmaceutical products and services. The company focuses on the manufacture, marketing, promotion, and sale of drugs. Its products include Plendi, XinHuoSu, Stulln, XiDaKang, YiNuoShu, DanShenTong, Hirudoid, NuoDiKang, Combizym, GanFuLe, Imdur, Parlodel, Lamisil, YinLianQingGan, and MOVICOL.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.